effects of therapeutic nutrition with the apitherapeutic product apiter in dogs and cats in rickets disease

In order to create the product APITER the researches were carried out in theInstitute for Beekeeping Research and Development - Bucharest and the product waspreclinical and clinical tested in the Medical Clinic of the Veterinary MedicineFaculty from Bucharest.The increasing interest in internationally context for nonconventionallytherapies and especially for the apitherapy and phitotherapy used inveterinary purpose determined us to study the effects of such therapies in bonediseases (rickets) in dogs and cats using a new product -Apiter.The clinicalexperiments were done in the period - October 2004 – February 2006 using a lot of70 individuals (dogs and cats), of different ages between 6 weeks and 7 years withosteo-articulars disorders of rickety type for young individuals and osteomalacia(adult rickets), in treatment series of 10 and 30 days.The clinical investigations werecompleted by radiological exams and biochemical determinations (Ca, Mg, P andalkaline phosphatase), the resulted values being registered before and aftertreatment.The obtained results shown us that the tested methods with the newproduct APITER, applied on dogs and cats with rickets disease were as efficiently asthe classic nutrition methods.The therapeutic efficiency of the new product wasproved by the increased values of Calcium - from 4 mg/dl to 9,2-11,5 mg/dl,Phosphor –from 1,6-3,81 mg/dl to 4,1-5,7 mg/dl, the normalization of the Mg values(2,5-3 mg/dl), the decreasing of alkaline phosphatase (116-443 UI/l la 77-187 U/I)concomitantly with the normalization of hepatic tests (ALT, GGT, AP, TBIL).